Azithromycin
- TRADE NAMES: AzaSite (Merck); Azenil; Azitrocin; Azitromax; Zeto; Zithromax (Pfizer); Zitromax; Zmax
- INDICATIONS: Infections of the upper and lower respiratory tract, skin infections, sexually transmitted diseases, conjunctivitis (ophthalmic preparations only)
- CLASS: Antibacterial, Antibiotic, macrolide
- HALF-LIFE: 68 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aminophylline, Antacids, Artemether/Lumefantrine, Astemizole, Atorvastatin, Betrixaban, Bromocriptine, Cabergoline, Colchicine, Coumarins, Cyclosporine, Digoxin, Droperidol, Ergotamine, Fluvastatin, Lovastatin, Methysergide, Mizolastine, Oral typhoid vaccine, Pimozide, Pravastatin, Quetiapine, Reboxetine, Rifabutin, Ritonavir, Simvastatin, Venetoclax, Warfarin
PREGNANCY CATEGORY: B
AzaSite is for topical ophthalmic use only (for reactions see [Ophth] below).
Please login to see the rest of this drug profile
SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
LOCAL
NEUROMUSCULAR/SKELETAL
OCULAR
OTIC
RENAL
RESPIRATORY
OTHER
Page last updated 03/05/2019
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
